Internal Medicine · Guaynabo, PR
NPI
1922048206
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2 Carr. 177 Atp. 207, Cond the Falls
Guaynabo, PR, 00966
Phone (787) 766-0430
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.9M
21,469 prescriptions
Company payments, 2025
$100
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Marta Diaz Nater prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,391 prescriptions and refills. In total Marta Diaz Nater wrote 21,469 Medicare prescriptions that cost $1.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 1,391 | 2,723 | 313 | $15K |
| Gabapentin Generic | 778 | 1,290 | 178 | $14K |
| Omeprazole Generic | 743 | 1,111 | 159 | $6,817 |
| Losartan Potassium Generic | 724 | 1,402 | 159 | $7,371 |
| Levothyroxine Sodium Generic | 705 | 1,365 | 161 | $9,416 |
| Synthroid Levothyroxine Sodium | 614 | 1,117 | 128 | $53K |
| Metformin Hcl Generic | 545 | 1,032 | 119 | $3,882 |
| Rosuvastatin Calcium Generic | 544 | 982 | 124 | $6,721 |
| Amlodipine Besylate Generic | 486 | 964 | 119 | $2,792 |
| Simvastatin Generic | 457 | 915 | 106 | $3,714 |
| Metoprolol Succinate Generic | 389 | 719 | 89 | $6,236 |
| Pantoprazole Sodium Generic | 369 | 577 | 86 | $3,842 |
| Ibandronate Sodium Generic | 314 | 617 | 83 | $9,491 |
| Pioglitazone Hcl Generic | 304 | 555 | 56 | $5,112 |
| Irbesartan Generic | 300 | 531 | 63 | $7,484 |
Brand drugs: 3,173 claims; generic drugs: 18,186 claims; opioid claims: 171.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marta Diaz Nater $100 ($100 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $75.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.